Drug intelligence / Profile preview

VIA Disc NP

Development stage
Preclinical
Lead developer
Vivex Biologics
Modality
Adoptive Cell Transfer → Cell Therapies, Other Cell Types → Cell Therapies, Stem Cell Therapies → Cell Therapies
Administration
Intradiscal
01

Overview

VIA Disc NP is an off-the-shelf, minimally invasive, injectable allograft composed of processed human nucleus pulposus (NP) tissue derived from donor intervertebral discs. It is designed to supplement and restore the natural cushioning function of degenerated lumbar intervertebral discs by replacing lost or damaged nucleus pulposus tissue. The product consists of dehydrated nucleus pulposus particulate that is mixed with saline prior to injection and delivered into the center of the affected disc via a spinal needle under fluoroscopic guidance. By restoring hydration and biomechanical properties similar to healthy disc tissue, VIA Disc NP aims to relieve chronic low back pain associated with degenerative disc disease (DDD), improve mobility, and potentially delay or eliminate the need for surgical interventions such as spinal fusion or artificial disc replacement[1][2][4][6][10]. Clinical studies have shown promising results in pain reduction and functional improvement following treatment.

Brand names
VIA Disc NP
Other names
VIA Disc Nucleus Pulposus AllograftVIA Disc NP allograft

Beyond the preview

Go deeper on VIA Disc NP.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on VIA Disc NP.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call